New agentic platform for real-world data debuts with its first agent, Atlas Patient Analytics, built on Norstella's structured and unstructured RWD foundation — with additional agents on the way
NEW YORK, Sept. 29, 2026 /PRNewswire-PRWeb/ -- Norstella, the global biopharma commercial intelligence and data company, today launched its new agentic platform for real-world data.
The platform is built on Norstella's curated, integrated real-world data asset and centralized delivery system. With it, teams have full transparency: They can pull data on demand, track every request from status updates to SLAs, and explore other data modalities across NorstellaLinQ to enrich their cohorts.
The platform's agent, Atlas Patient Analytics, gives biopharma teams something the current wave of AI plus real-world data tools hasn't delivered: not just an answer, but a defensible, reproducible cohort. Teams build, explore, and reuse patient cohorts on Norstella's real-world data through natural conversation — and can see, verify, and rerun every criterion behind the result.
"Every breakthrough therapy starts with understanding the right patients," said Kris Kaneta, Chief Product and Innovation Officer. "With our new agentic platform for real-world data, people doing the foundational work of cohort-building get swift, transparent access to the data they need. This shift is the difference between a therapy that reaches patients in need and one that doesn't."
Atlas Patient Analytics is built for real-world evidence (RWE), health economics and outcomes research (HEOR), feasibility, and data-science teams who already license Norstella real-world data but still depend on manual SQL and custom analyst pulls to turn that data into a usable cohort. It is also built for commercial analytics and market access teams who are looking to size a patient population themselves, without waiting on a data pull.
Unlike tools that pair real-world data with a general-purpose chat assistant and return a count with no visible logic, Atlas Patient Analytics shows the inclusion and exclusion criteria, code sets, and query logic behind a supported cohort and preserves that definition so it can be rerun and verified, not just recalled.
"Every real-world data vendor is going to tell you they're fast," said Ilan Behm, SVP of RWD and Commercial Strategy at Norstella. "Fast isn't the differentiator anymore — everyone got fast. What matters is whether the answer is one you can stand behind. Norstella customers already license some of the richest real-world data in specialty and complex therapeutic areas — Atlas Patient Analytics turns that into a cohort you can defend, rerun, and take into your own environment, in the time it used to take to get a meeting on an analyst's calendar."
Atlas Patient Analytics is designed for teams that currently license Norstella real-world data, where the agent makes that data faster and easier to use, reuse, and expand. Key features include:
- Built on NorstellaLinQ: Runs on Norstella's real-world data foundation spanning more than 85 million EHR-covered lives, 350 million unique patients, and 3 billion clinical notes, with roughly seven years of linked patient history
- Conversational cohort building: Describe the population you need in plain language, refine the definition through dialogue, and review inclusion/exclusion criteria, code sets, and logic in an inspection-first view before running the analysis
- Portable by design: Cohort-level data and query logic move into your own environment — S3, SFTP, Snowflake Databricks — and it's purpose-built on Norstella's specialty real-world data in complex therapeutic areas, not a general-purpose AI layer on a one-size-fits-all data set
- Centralized delivery: Self-service, on-demand data delivery with full visibility into request status, data enhancements and SLA history
- "Bring your own code" lists: Upload custom code lists to shape a cohort definition around your own criteria
- Reproducible, not just recalled: Run a supported cohort to produce an authoritative patient count, attrition, and a standard descriptive profile, with the underlying definition and logic preserved so it can be rerun and reused
- Feasibility without full access: Where permitted, preview feasibility across additional Norstella real-world data you don't yet license, without gaining full access to it
- Intentionally flexible: Available now through a managed, conversation-led experience, with API access for dashboard feeds and a governed MCP access path for customer cloud and agent environments planned for later in 2026
Atlas Patient Analytics builds on the momentum of Norstella Atlas, the agentic platform that powers all of Norstella, and Atlas CI, the first agent on the platform, built for competitive intelligence teams. Atlas Patient Analytics extends that same agentic approach to real-world data and is one of roughly a half-dozen additional agents Norstella plans to bring to market across the platform before the end of the year, each purpose-built for specific biopharma teams and use cases.
"Atlas Patient Analytics is proof of where Norstella is headed," said Kaneta. "But identifying the right patients is only the beginning. Biopharma teams need to understand those patients in depth — their treatment journeys, the HCPs treating them, and the clinical and access dynamics shaping their care. With Atlas and our AI development engine powering all that we do, we're excited to bring a suite of AI agents to market that will provide value across the drug life cycle."
Norstella will be demonstrating recently launched agents at BioTechX USA in Boston on Sept. 29 & 30.
About Norstella
Norstella is the AI company for biopharma's highest-stakes decisions. A global life sciences company trusted by every Top 100 pharma company and industry experts the world over, Norstella unites market-leading brands — Citeline, Evaluate, MMIT, Panalgo, Skipta, and The Dedham Group — turning decision-grade data, insights and expertise into AI you can act on. Visit norstella.ai and follow us on LinkedIn for more.
Media Contact
Diffusion PR for Norstella, Norstella, 1 888-200-9288, [email protected], www.norstella.com
SOURCE Norstella
Share this article